Internal Medicine · Baltimore, MD
NPI
1992741789
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
9114 Philadelphia Rd, Suite 300
Baltimore, MD, 21237
Phone (410) 918-0020
Groups this clinician bills Medicare through
Medicare paid, 2024
$187K
4,018 services
Medicare patients, 2024
661
Average age 76
Drug cost, 2024
$920K
10,791 prescriptions
Company payments, 2025
$1,936
From 21 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kevin G Schendel was code 99213 (office e&m - established), 1,532 times for 559 patients. In total Kevin G Schendel billed 4,018 services in 24 codes, and Medicare paid $187K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,532 | 559 | $40.46 | $62K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 938 | 422 | $12.36 | $12K |
| 99214 Office E&M - Established | Office | 488 | 266 | $63.12 | $31K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 373 | 373 | $134.41 | $50K |
| 93000 Electrocardiogram | Office | 171 | 153 | $9.46 | $1,618 |
| G0008 Administration of influenza virus vaccine | Office | 142 | 140 | $33.77 | $4,795 |
| 90656 Vaccine Product | Office | 130 | 130 | $21.90 | $2,847 |
| 99214 Office E&M - Established | Facility | 51 | 42 | $66.55 | $3,394 |
| 99496 Chronic, Principal, and Transitional Care Management | Office | 38 | 31 | $231.32 | $8,790 |
| 99212 Office E&M - Established | Office | 28 | 28 | $18.57 | $520 |
| 99495 Chronic, Principal, and Transitional Care Management | Office | 24 | 22 | $171.00 | $4,104 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 18 | 18 | $29.60 | $533 |
| 99215 Office E&M - Established | Office | 14 | 11 | $102.52 | $1,435 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 13 | 13 | $13.41 | $174 |
| 99204 Office E&M - New | Office | 11 | 11 | $85.53 | $941 |
By year: 2022 $264K for 4,846 services; 2023 $207K for 3,301 services; 2024 $187K for 4,018 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 197 | 183 | $2.94 | $579 |
Medicare prescription drug claims, 2024
In 2024, the drug Kevin G Schendel prescribed most often to Medicare patients was Amlodipine Besylate, with 449 prescriptions and refills. In total Kevin G Schendel wrote 10,791 Medicare prescriptions that cost $920K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 449 | 1,226 | 121 | $3,590 |
| Atorvastatin Calcium Generic | 435 | 1,226 | 123 | $6,097 |
| Levothyroxine Sodium Generic | 431 | 1,178 | 107 | $4,357 |
| Losartan Potassium Generic | 419 | 1,140 | 120 | $5,295 |
| Pravastatin Sodium Generic | 274 | 816 | 81 | $6,311 |
| Lisinopril Generic | 233 | 667 | 62 | $1,965 |
| Escitalopram Oxalate Generic | 222 | 539 | 59 | $3,379 |
| Furosemide Generic | 207 | 427 | 60 | $1,065 |
| Metoprolol Succinate Generic | 196 | 556 | 57 | $3,469 |
| Metformin Hcl Generic | 195 | 548 | 62 | $1,530 |
| Gabapentin Generic | 192 | 422 | 56 | $3,311 |
| Rosuvastatin Calcium Generic | 192 | 511 | 58 | $3,969 |
| Pantoprazole Sodium Generic | 188 | 509 | 59 | $3,117 |
| Omeprazole Generic | 186 | 496 | 53 | $2,292 |
| Hydrochlorothiazide Generic | 175 | 493 | 50 | $1,023 |
Brand drugs: 1,099 claims; generic drugs: 9,667 claims; opioid claims: 167.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kevin G Schendel $1,936 ($1,936 in general payments such as food, travel and fees) from 21 companies. The largest payer was Novo Nordisk Inc with $309.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 14 | $309 |
| Amgen Inc. AMGN | 13 | $251 |
| Dexcom, Inc. DXCM | 6 | $225 |
| Abbvie Inc. ABBV | 12 | $190 |
| Abbott Laboratories ABT | 2 | $127 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $121 |
| Lilly USA, LLC LLY | 6 | $117 |
| E.R. Squibb & Sons, L.L.C. BMY | 6 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 4 | $97.35 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $76.44 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.